Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Treatment
21 results:

  • 1. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
    Li Y; Tao T; Liu Y
    BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A CT-based radiomics nomogram for predicting histopathologic growth patterns of colorectal liver metastases.
    Sun C; Liu X; Sun J; Dong L; Wei F; Bao C; Zhong J; Li Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9543-9555. PubMed ID: 37221440
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.
    Ghatak S; Hascall VC; Markwald RR; Misra S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451103
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
    Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
    J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Poly(ADP-Ribose) Polymerase Inhibition Sensitizes colorectal cancer-Initiating Cells to Chemotherapy.
    Jarrar A; Lotti F; DeVecchio J; Ferrandon S; Gantt G; Mace A; Karagkounis G; Orloff M; Venere M; Hitomi M; Lathia J; Rich JN; Kalady MF
    Stem Cells; 2019 Jan; 37(1):42-53. PubMed ID: 30353615
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets cancer-Initiating Cells in Preclinical Models of colorectal cancer.
    Haynes J; McKee TD; Haller A; Wang Y; Leung C; Gendoo DMA; Lima-Fernandes E; Kreso A; Wolman R; Szentgyorgyi E; Vines DC; Haibe-Kains B; Wouters BG; Metser U; Jaffray DA; Smith M; O'Brien CA
    Clin Cancer Res; 2018 May; 24(9):2116-2127. PubMed ID: 29476017
    [No Abstract]    [Full Text] [Related]  

  • 8. Round cell sarcoma of the colon with cic rearrangement.
    Maghrebi H; Batti R; Zehani A; Chrait N; Rais H; Makni A; Haddad A; Ayadi M; Daghfous A; Jrad M; Kchir N; Bensafta Z; Mezlini A
    BMC Res Notes; 2017 Nov; 10(1):582. PubMed ID: 29121995
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. BCL-X
    Carné Trécesson S; Souazé F; Basseville A; Bernard AC; Pécot J; Lopez J; Bessou M; Sarosiek KA; Letai A; Barillé-Nion S; Valo I; Coqueret O; Guette C; Campone M; Gautier F; Juin PP
    Nat Commun; 2017 Oct; 8(1):1123. PubMed ID: 29066722
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.
    Cha ST; Tan CT; Chang CC; Chu CY; Lee WJ; Lin BZ; Lin MT; Kuo ML
    Nat Cell Biol; 2016 Sep; 18(9):993-1005. PubMed ID: 27525719
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model.
    Bellamkonda K; Chandrashekar NK; Osman J; Selvanesan BC; Savari S; Sjölander A
    BMC Cancer; 2016 Jul; 16():425. PubMed ID: 27388564
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
    Rowehl RA; Burke S; Bialkowska AB; Pettet DW; Rowehl L; Li E; Antoniou E; Zhang Y; Bergamaschi R; Shroyer KR; Ojima I; Botchkina GI
    PLoS One; 2014; 9(6):e99091. PubMed ID: 24921652
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A.
    Lotti F; Jarrar AM; Pai RK; Hitomi M; Lathia J; Mace A; Gantt GA; Sukhdeo K; DeVecchio J; Vasanji A; Leahy P; Hjelmeland AB; Kalady MF; Rich JN
    J Exp Med; 2013 Dec; 210(13):2851-72. PubMed ID: 24323355
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Self-renewal as a therapeutic target in human colorectal cancer.
    Kreso A; van Galen P; Pedley NM; Lima-Fernandes E; Frelin C; Davis T; Cao L; Baiazitov R; Du W; Sydorenko N; Moon YC; Gibson L; Wang Y; Leung C; Iscove NN; Arrowsmith CH; Szentgyorgyi E; Gallinger S; Dick JE; O'Brien CA
    Nat Med; 2014 Jan; 20(1):29-36. PubMed ID: 24292392
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chemotherapy sensitizes colon cancer initiating cells to Vγ9Vδ2 T cell-mediated cytotoxicity.
    Todaro M; Orlando V; Cicero G; Caccamo N; Meraviglia S; Stassi G; Dieli F
    PLoS One; 2013; 8(6):e65145. PubMed ID: 23762301
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.
    Lin WM; Karsten U; Goletz S; Cheng RC; Cao Y
    Int J Exp Pathol; 2011 Apr; 92(2):97-105. PubMed ID: 21070402
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
    Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
    Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer.
    Jefford M; Michael M; Rosenthal MA; Davis ID; Green M; McClure B; Smith J; Waite B; Zalcberg J
    Invest New Drugs; 2004 Apr; 22(2):185-92. PubMed ID: 14739668
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long-term outcome of urinary function after extended lymphadenectomy in patients with distal rectal cancer.
    Matsuoka N; Moriya Y; Akasu T; Fujita S
    Eur J Surg Oncol; 2001 Mar; 27(2):165-9. PubMed ID: 11289753
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.